Drug profile · INN
gadoversetamide
OPTIMARK
gadoversetamide (OPTIMARK) is a diagnostic agent. Route of administration: injection. Current US regulatory status: approved.
FDA: approved EMA: withdrawn Various (V08) V08CA06
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — gadoversetamide
- US status
- approved
- Class
- Various (V08)
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
gadoversetamide (OPTIMARK) is a diagnostic agent. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN gadoversetamide
Brand OPTIMARK
Mechanism Diagnostic agent
Therapeutic class Various (V08)
Route INJECTION
Formulation INJECTABLE
ATC code V08CA06
Mechanism of action
Diagnostic agent
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | withdrawn | — |
Related & competitor drugs
Frequently asked questions
What is gadoversetamide?
gadoversetamide (OPTIMARK) is a diagnostic agent. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for gadoversetamide?
OPTIMARK is a marketed brand name for gadoversetamide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of gadoversetamide?
gadoversetamide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.